Delivery of antimicrobial peptides to low-pH sites is a significant challenge, and results in reduced treatment efficacy for vaginal infections. Chitosan nanoparticles (CNPs) could be ideal vehicles for drugs to acidic pH environments and sustain their therapeutic effects. CNPs were synthesized using the ionic gelation technique and loaded with Kn2-7 peptide. The CNPs were characterized by dynamic light scattering, Fourier transform infrared spectroscopy, high-resolution transmission and scanning electron microscopes. The stability and antibacterial effects of Kn2-7-loaded CNPs were evaluated at low and normal pH levels. The CNPs had a size distribution of 327–416 nm and a zeta potential of 9.61–23.9 mV. The size distribution (340.2–753.7 nm) and Zeta potential (15.9–67.7 mV) of CNPs changed after loading Kn2-7. The CNPs loading capacity and Kn2-7 entrapment efficiency were 35.6% and 78.3%, respectively. The Kn2-7-CNPs were not stable at low-pH and released Kn2-7 instantly; however, stabilization of Kn2-7-CNPs with poly (acrylic acid) (PAA) and tripolyphosphate (TPP) increased their stability and sustained Kn2-7 release at acidic pH. The Kn2-7-CNPs_1 mg/mL TPP-PAA inhibited the growth of Staphylococcus aureus at pH 3.8 better than the Kn2-7 alone. Therefore, the Kn2-7-CNPs_1mg/mL TPP-PAA could serve as a promising candidate for protecting and delivering drugs in low-pH environments.
HPV16 E6 oncoprotein is a critical driver of cervical cancer, necessitating high-specificity diagnostic and therapeutic agents. This study presents an in silico selection of DNA aptamers targeting the HPV16 E6 oncoprotein through a pipeline of structure-based virtual screening and 250 ns Molecular Dynamics (MD) simulations, performed with GROMACS 2019 and the CHARMM36M. Using AutoDock VinaXB and HADDOCK, eight candidates were evaluated against the F2 RNA benchmark. MM/PBSA calculations identified Apt 9 (−143.76 kcal/mol) as the most potent lead, surpassing the affinity of the F2 control (−142.80 kcal/mol). Apt 8 emerged as a key consensus lead, exhibiting superior structural stability (RMSD 0.23 nm) and the most robust interaction network (11.49 hydrogen bonds). Notably, these leads primarily target critical Histidine residues (His78, His118, and His126) on the E6 protein. These results designate Apt 9 and Apt 8 as high-priority candidates for experimental validation, providing a robust theoretical foundation for novel HPV16-targeted interventions.